Seek Returns

ELAN vs. SNY: Elanco Animal Health vs. Sanofi Stock Comparison

How do Elanco Animal Health (ELAN) and Sanofi (SNY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Elanco Animal Health (ELAN) and Sanofi (SNY) are both classified in the Pharmaceuticals sub-industry within the broader Pharmaceuticals industry, placing them in the closest GICS peer bucket.

Elanco Animal Health (ELAN) trades as ordinary local shares, while Sanofi (SNY) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for Elanco Animal Health (ELAN) and Sanofi (SNY)
Profile ItemELANSNY
NameElanco Animal Health IncorporatedSanofi ADR
Country/RegionUnited StatesFrance
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticalsPharmaceuticals
GICS Sub-IndustryPharmaceuticalsPharmaceuticals
Market Capitalization12.86 billion USD112.71 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateSeptember 20, 2018July 1, 2002
Security TypeCommon StockADR

Price Performance

Cumulative Growth

ELAN
SNY
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. Sanofi (SNY), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Elanco Animal Health (ELAN) and Sanofi (SNY). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Elanco Animal Health (ELAN) and Sanofi (SNY). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Total Return (1Y)24.03%2.73%
Total Return (3Y, Annualized)37.47%6.89%
Total Return (5Y, Annualized)-4.24%3.16%

Risk Profile

Drawdown History

ELAN
SNY
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. Sanofi (SNY), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Elanco Animal Health (ELAN) and Sanofi (SNY). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Elanco Animal Health (ELAN) has an aggressive beta of 1.65, indicating higher sensitivity to broad-market moves, while Sanofi (SNY) is defensive at 0.28 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Volatility (1Y, Annualized)43.57%23.60%
Beta (5Y)1.650.28
Max Drawdown (5Y)-75.59%-33.52%
Avg. Volume (3M)5.65M3.29M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ELAN and SNY are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Sharpe Ratio (1Y)0.45-0.07
Sortino Ratio (1Y)0.66-0.10

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Sanofi (SNY) earns 5.72% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.72%

Max
109.18%
Q3
6.23%
SNY
5.72%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): ELAN does not report ROE, so it has no value marker; SNY is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile Sanofi (SNY) reports 8.20%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.20%

Max
18.05%
SNY
8.20%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Sanofi (SNY) at 30.89% operates in the top operating margin quartile, ahead of Elanco Animal Health (ELAN) at 6.64%, which runs around its industry’s norm.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.89%

Max
83.12%
SNY
30.89%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
ROE (TTM)--5.72%
ROA (TTM)--5.31%
Net Margin (TTM)-2.86%8.20%
Operating Margin (TTM)6.64%30.89%
Gross Margin (TTM)56.18%73.68%

Growth

Revenue Growth

Both Elanco Animal Health (ELAN) at 6.22% and Sanofi (SNY) at 5.49% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their Revenue Growth across different time periods.

EPS Growth

Sanofi (SNY) at 39.43% is around its peer norm for EPS growth, while Elanco Animal Health (ELAN) at -169.12% drops into the bottom quartile, signaling weaker earnings momentum.

Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Revenue Growth (YoY)6.22%5.49%
Revenue Growth (3Y CAGR)2.25%4.82%
EPS Growth (YoY)-169.12%39.43%
EPS Growth (3Y CAGR)--6.02%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Sanofi (SNY) shows current ratio of 1.12 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.12

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
SNY
1.12
Min
0.10
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): ELAN does not report current ratio, so it has no value marker; SNY is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Both Elanco Animal Health (ELAN) at 0.64 and Sanofi (SNY) at 0.27 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27

Max
1.42
Q3
0.65
SNY
0.27
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Current Ratio (MRQ)--1.12
Debt / Equity (MRQ)0.640.27
Net Debt / EBITDA3.490.96

Dividends

Dividend Yield (TTM)

Neither Elanco Animal Health (ELAN) nor Sanofi (SNY) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

SNY
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Sanofi (SNY) reports payout ratio above 100% at 119.86%, meaning dividends exceeded current-period earnings; Elanco Animal Health (ELAN) pays no dividend (payout 0.00%).

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

119.86%

SNY
119.86%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%119.86%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Sanofi (SNY) trades at 23.40 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

23.40

Max
85.34
Q3
43.46
Median
26.69
SNY
23.40
Q1
13.30
Min
0.07
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): ELAN does not report P/E ratio, so it has no value marker; SNY is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Both Elanco Animal Health (ELAN) at 2.50 and Sanofi (SNY) at 2.21 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.21

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
SNY
2.21
Min
0.01
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Sanofi (SNY) at 1.38 sits in the lower P/B ratio quartile against book while Elanco Animal Health (ELAN) at 1.95 is valued near its industry’s middle — SNY is cheaper on assets, though weigh it against ROE and asset quality.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.38

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
SNY
1.38
Min
-5.59
Loading chart…
Elanco Animal Health (ELAN) vs. Sanofi (SNY): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Elanco Animal Health (ELAN) and Sanofi (SNY)
MetricELANSNY
P/E Ratio (TTM)--23.40
P/S Ratio (TTM)2.502.21
P/B Ratio (MRQ)1.951.38
Free Cash Flow Yield (TTM)--7.17%